HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
TLRY
Tilray Brands Inc
Healthcare Drug Manufacturers - Specialty & Generic · British Columbia, Canada · Reports in usd
Market Cap: $544.3M
Market Cap
$544.3M
Enterprise Val
$708.1M
P/E Ratio
-4.48
P/B Ratio
0.34
Trailing PEG (1Y)
0.05
As Of
Aug 19, 2026

Overview & Key Metrics

Reporting period: May 31, 2026 · Q4 2026
Book Value$1.59B
Gross Margin32.13%
Profit Margin32.13%
Return on Equity-7.72%
Return on Assets-5.66%
Current Ratio2.21
Debt/Equity0.25
LT Debt/Equity0.22
Revenue Per Share2.42

Income Statement

May 31, 2026
Revenue$281.7M
Cost of Revenue$191.2M
Gross Profit$90.5M
R&D$180.0K
SG&A$88.6M
Operating Expenses$107.0M
Operating Income-$16.5M
Interest Expense$6.6M
Tax Expense$13.9M
Net Income-$49.6M
EPS (Basic)$-0.44
EPS (Diluted)$-0.44
EBIT-$29.1M
EBITDA-$9.7M
Consolidated Income-$37.9M
Non-Controlling Interests$11.6M

Balance Sheet

May 31, 2026
Cash & Equivalents$229.3M
Accounts Receivable$189.2M
Inventory$301.2M
Current Assets$792.1M
LT Investments$7.2M
Property, Plant & Equipment$722.5M
Intangibles$795.1M
Non-Current Assets$1.54B
Total Assets$2.33B
Accounts Payable$318.1M
Current Debt$40.3M
Current Liabilities$358.4M
LT Debt$358.1M
Non-Current Liabilities$374.8M
Total Liabilities$733.1M
Total Debt$398.4M
Retained Earnings-$4.97B
Shareholder Equity$1.61B
Shares Outstanding116,548,663

Cash Flow Statement

May 31, 2026
Operating Cash Flow-$37.3M
Investing Cash Flow-$51.2M
Financing Cash Flow$68.2M
CapEx-$8.4M
Free Cash Flow-$45.8M
Depreciation & Amort.$19.3M
Stock-Based Comp$14.9M
Acquisitions / Disposals-$53.7M
Investment Activity$11.0M
Debt Issued/Repaid-$16.7M
Equity Issued/Repaid$82.5M
Dividends Paid$0.00
Net Change in Cash-$20.2M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h